Dynamic magnetic resonance perfusion imaging of brain tumors
- PMID: 15477637
- DOI: 10.1634/theoncologist.9-5-528
Dynamic magnetic resonance perfusion imaging of brain tumors
Abstract
In this paper, we review the technique of contrast-enhanced magnetic resonance (MR) perfusion imaging of brain neoplasms, with an emphasis on its clinical applications and utility. We start with a discussion of MR perfusion techniques available today and their relative merits and shortcomings. Next, the ability of MR perfusion to provide a preoperative assessment of tumor histology is examined. We also discuss the role of MR perfusion in helping guide tumor biopsy, and its advantages over more conventional methods. We will scrutinize the use of MR perfusion for assessing true lesion extent, in contrast to conventional MR imaging and other MR techniques. We will discuss the role of MR perfusion in differentiating treatment effects, such as radiation necrosis, from tumor recurrence. Finally, the future potential applications of this technology in the setting of novel antiangiogenic therapies for brain tumors will be addressed.
Similar articles
-
[Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy].Radiologe. 2003 May;43(5):388-95. doi: 10.1007/s00117-003-0887-6. Radiologe. 2003. PMID: 12764588 German.
-
Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.AJR Am J Roentgenol. 2012 Jan;198(1):19-26. doi: 10.2214/AJR.11.7417. AJR Am J Roentgenol. 2012. PMID: 22194475 Review.
-
[Brain MR perfusion and MR spectroscopy in differentiation of radiation necrosis from tumor recurrence (case report)].Tani Girisim Radyol. 2004 Dec;10(4):263-7. Tani Girisim Radyol. 2004. PMID: 15611913 Turkish.
-
The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging.Clin Radiol. 2001 Feb;56(2):94-8. doi: 10.1053/crad.2000.0560. Clin Radiol. 2001. PMID: 11222064
-
Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.Neurosurg Clin N Am. 2010 Jan;21(1):181-6. doi: 10.1016/j.nec.2009.08.003. Neurosurg Clin N Am. 2010. PMID: 19944976 Review.
Cited by
-
Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.J Clin Oncol. 2015 Apr 1;33(10):1197-213. doi: 10.1200/JCO.2014.55.9575. Epub 2015 Feb 23. J Clin Oncol. 2015. PMID: 25713439 Free PMC article.
-
Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.Neuroradiology. 2006 Oct;48(10):773-81. doi: 10.1007/s00234-006-0120-1. Epub 2006 Aug 26. Neuroradiology. 2006. PMID: 16937146
-
Perfusion CT imaging of brain tumors: an overview.AJNR Am J Neuroradiol. 2011 Oct;32(9):1570-7. doi: 10.3174/ajnr.A2263. Epub 2010 Nov 4. AJNR Am J Neuroradiol. 2011. PMID: 21051510 Free PMC article. Review.
-
High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide.Invest Radiol. 2009 Jul;44(7):375-83. doi: 10.1097/RLI.0b013e3181a8afea. Invest Radiol. 2009. PMID: 19448552 Free PMC article.
-
Early time points perfusion imaging: theoretical analysis of correction factors for relative cerebral blood flow estimation given local arterial input function.Neuroimage. 2011 Jul 1;57(1):182-189. doi: 10.1016/j.neuroimage.2011.03.060. Epub 2011 Apr 8. Neuroimage. 2011. PMID: 21497658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical